MeSH D007153 - immunologic deficiency syndromes
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D007154:Immune system diseases
D007153:
Immunologic deficiency syndromes
D000081207:Primary immunodeficiency diseases
D000361:Agammaglobulinemia
0 Companies
0 Drugs
Success rate
D004406:Dysgammaglobulinemia
0 Companies
0 Drugs
Success rate
D006800:Deltaretrovirus infections
0 Companies
0 Drugs
Success rate
D008231:Lymphopenia
0 Companies
0 Drugs
Success rate
D010585:Phagocyte bactericidal dysfunction
0 Companies
0 Drugs
Success rate
D015658:Hiv infections
D017074:Common variable immunodeficiency
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Baxalta | Human normal immunoglobulin | HyQvia | 2013-05-16 | |||
| CSL Behring | Globulin, immune | Hizentra | 2011-04-14 | |||
| Globulin, immune | Privigen | 2008-04-24 | ||||
| Grifols | Human normal immunoglobulin | Flebogamma DIF (previously Flebogammadif) | 2007-07-23 | |||
| Takeda | Human normal immunoglobulin | Kiovig | 2006-01-18 |
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/11
Phase 3
0%0/3
Approved: 0Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use